April 1, 2016 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. Sponsored By:

First Page		Document Content
Date: 2016-04-07 10:30:28 Business Pharmaceutical sciences Biotechnology Pharmacy Pharmaceutical industry Bristol-Myers Squibb Daiichi Sankyo Eli Lilly and Company Biopharmaceutical GlaxoSmithKline		April 1, 2016 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. Sponsored By: Add to Reading List Source URL: www.dcat.org Download Document from Source Website File Size: 324,19 KB Share Document on Facebook

	INDUSTRY ISSUES What Is a Biopharmaceutical? DocID: 1v8Wa - View Document
	Curtana Pharmaceuticals Selected to Present at Inaugural University Startups Demo Day in Washington, DC AUSTIN, TX – September 7, 2016 – Curtana Pharmaceuticals, a privately-held, preclinical stage biopharmaceutical DocID: 1v7ko - View Document
	INDUSTRY ISSUES What Is a Biopharmaceutical? DocID: 1v72B - View Document
	Beyond Operational Excellence through Digital Continuity Sustainable Health for Biopharmaceutical Manufacturing by Julie Fraser and Amy Rowell DocID: 1v5W2 - View Document
	TERMINOLOGY What is a Biopharmaceutical? DocID: 1v5mX - View Document